CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 18 enrolled
Drug / intervention
Positive Expiratory Pressuredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02696980
NCT02696980Phase 2Completed

Increased Lung Volume as Rescue Therapy for Asthma

University of Vermont·interventional·Posted Mar 2, 2016·Updated Jul 17, 2024

In Brief

A Phase 2 clinical trial evaluating Positive Expiratory Pressure for Asthma. Completed, enrolled 18 participants across 1 site.

Detailed Summary

The purpose of this study is to test the effect of increasing lung volume with a simple hand-held device to both prevent, and also to relieve, airway constriction in people with asthma and a BMI ≥ 30 kg/m2. Twenty people with late onset non-allergic asthma and a BMI of ≥ 30 kg/m2 will be recruited. The efficacy of elevating lung volume on both preventing and reversing bronchoconstriction will be tested. Lung volume will be modulated by breathing out against a small level of resistance (positive expiratory pressure).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20162017201820192020202120222023202420252026
First PostedMar 2, 2016
Enrollment StartApr 1, 2016
Primary CompletionApr 1, 2019
Study CompletionJun 1, 2019
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 10.3 years ago

Interventions

Positive Expiratory Pressuredevice

Patient will exhale against positive expiratory pressure 0 mm or 10 mm while inhaling methacholine